ArticleACR open rheumatology2026

Severe Hepatic Adverse Event Induced by Anti-HER2 Therapy in Breast Cancer: A Case of Successful Immunotherapy With Baricitinib.

Yufei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.